Viking Therapeutics, Inc. (VKTX)
Nasdaq: VKTX · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2014
Who owns Viking Therapeutics, Inc.
As filed with the SECHolders of 5% or more
2
Fmr LLC holds 5.1% of COMMON STOCK, as its SCHEDULE 13G/A filed Nov 5, 2025 says.
Directors and officers
11
report now, of 15 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Fmr LLC
SCHEDULE 13G/A · filed Nov 5, 2025 · COMMON STOCK · 8.7% in Aug 6, 2025
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 23, 2025 · Common Stock · reported falling below 5%, from 5.3% in Feb 4, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What VKTX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Ligand Pharmaceuticals Incorporated
A company bought · acquisition · owns, named in the 10-K filed Feb 11, 2026
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Feb 26, 2025.
Insider tradesForm 4
20sales
1purchases
0sales on a scheduled plan
5people selling
$22.3Msold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 16 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Lian Brian | President & CEO | 6 | $14.0M | 0 | 0 | $0 |
| Zante Greg | Chief Financial Officer | 6 | $2.8M | 0 | 0 | $0 |
| Mancini Marianna | Chief Operating Officer | 6 | $2.7M | 0 | 0 | $0 |
| Rowland Charles A Jr | director | 1 | $2.1M | 0 | 0 | $0 |
| Foehr Matthew W | director | 1 | $600,000 | 0 | 0 | $0 |
| Aubuchon Neil William | Chief Commercial Officer | 0 | $0 | 0 | 1 | $100,000 |